瑞典限制氯头孢菌素在儿童中的使用瑞典国家卫生福利委员会公布了1986～1987年间药品不良反应综述,其中例举了头孢类抗生素中的氯头孢菌素(cefalor)。氯头孢菌素已报告的不良反应共129例,其中除3例外,其余都是儿童。绝大多数不良反应为皮肤及骨骼肌系统反应。在15名病人中还有血清病及发烧出现。鉴于这种情况,该委员会建议不应把氯头孢菌素当作治疗儿童耳鼻喉科感染的一线药,并建议除皮肤试验 Sweden limits the use of chlorocephalosporins in children The Swedish National Board of Health and Welfare published a summary of adverse drug reactions from 1986 to 1987, of which cephalosporins in cephalosporins were cited. A total of 129 adverse reactions have been reported with cephalosporins, with the exception of 3 except for children. The vast majority of adverse reactions for the skin and skeletal muscle system response. Serum disease and fever occurred in 15 patients. Given this situation, the committee recommended that cefazolin should not be considered as a first-line treatment for ENT infections in children and that skin tests other than skin tests